Superparamagnetic Poly (3-hydroxybutyrate-co-3 hydroxyvalerate) (PHBV) nanoparticles for biomedical applications

Electronic Journal of Biotechnology

Volumn 16, Issue 5, 2013, Pages

  Vilos, Cristian ^a,c   Gutiérrez, Marlen ^b,c   Escobar, Roberto A ^b,c   Morales, Francisco ^a   Denardin, Juliano C ^b,c   Velasquez, Luis ^a,c   Altbir, Dora ^b,c  

^a UNIVERSIDAD ANDRÉS BELLO   (Chile)

^b UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

^c Center for the Development of Nanoscience and Nanotechnology CEDENNA   (Chile)

Author keywords

Hyperthermia; Magnetic resonance image (MRI); Magnetite; PHBV; Polymeric nanoparticles

Indexed keywords

HYPERTHERMIA; MAGNETIC IRON OXIDE NANOPARTICLES; MAGNETIC RESONANCE IMAGES (MRI); MAGNETIC RESONANCE IMAGING CONTRAST AGENTS; MULTI-FUNCTIONAL NANOPARTICLES; PHBV; POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE); POLYMERIC NANOPARTICLES;

BIODEGRADABLE POLYMERS; CONTRAST MEDIA; DIAGNOSIS; DRUG DELIVERY; FUNCTIONAL POLYMERS; MAGNETIC RESONANCE IMAGING; MAGNETITE; MEDICAL APPLICATIONS; NANOPARTICLES; SUPERPARAMAGNETISM; SYNTHESIS (CHEMICAL); TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

MAGNETITE NANOPARTICLES;

FERUMOXSIL; POLY(3 HYDROXYBUTYRATE CO 3 HYDROXYVALERATE); POLYMER; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; IN VITRO STUDY; LIGHT SCATTERING; MAGNETIC FIELD; MALE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; RAT; SMALL INTESTINE; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 84884245553     PISSN: None     EISSN: 07173458     Source Type: Journal    
DOI: 10.2225/vol16-issue5-fulltext-8     Document Type: Article

References (33)

1. CORCHERO, J.L. and VILLAVERDE, A. (2009). Biomedical applications of distally controlled magnetic nanoparticles. Trends in Biotechnology, vol. 27, no. 8, p. 468-476. [CrossRef]
2. CORMODE, D.P.; SKAJAA, T.; FAYAD, Z.A. and MULDER, W.J.M. (2009). Nanotechnology in medical imaging: Probe design and applications. Arteriosclerosis Thrombosis and Vascular Biology, vol. 29, no. 7, p. 992-1000. [CrossRef]
3. DEMERLIS, C.C. and SCHONEKER, D.R. (2003). Review of the oral toxicity of polyvinyl alcohol (PVA). Food and Chemical Toxicology, vol. 41, no. 3, p. 319-326. [CrossRef]
4. DONG, Z.; XIE, S.; ZHU, L.; WANG, Y.; WANG, X. and ZHOU, W. (2011). Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery. Drug Delivery, vol. 18, no. 6, p. 441-450. [CrossRef]
5. FRIMPONG, R.A.; DOU, J.; PECHAN, M. and HILT, J.Z. (2010). Enhancing remote controlled heating characteristics in hydrophilic magnetite nanoparticles via facile co-precipitation. Journal of Magnetism and Magnetic Materials, vol. 322, no. 3, p. 326-331. [CrossRef]
6. GAO, J.; GU, H. and XU, B. (2009). Multifunctional magnetic nanoparticles: Design, synthesis, and biomedical applications. Accounts of Chemical Research, vol. 42, no. 8, p. 1097-1107. [CrossRef]
7. Gomez-Lopera, S.A.; Plaza, R.C. and Delgado, A.V. (2001). Synthesis and characterization of spherical magnetite/biodegradable polymer composite particles. Journal of Colloid and Interface Science, vol. 240, no. 1, p. 40-47. [CrossRef]
8. GUPTA, A.K. and GUPTA, M. (2005). Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials, vol. 26. no. 18, p. 3995-4021. [CrossRef]
9. Gutiérrez, M.; Escudey, M.; Escrig, J.; Denardin, J.C.; Altbir, D.; Fabris, J.D.; Cavalcante, L.C.D. and García-González, M.T. (2010). Preparation and characterization of magnetic composites based on a natural zeolite. Clays and Clay Minerals, vol. 58, no. 5, p. 589-595. [CrossRef]
10. HAW, C.Y.; MOHAMED, F.; CHIA, C.H.; RADIMAN, S.; ZAKARIA, S.; HUANG, N.M. and LIM, H.N. (2010). Hydrothermal synthesis of magnetite nanoparticles as MRI contrast agents. Ceramics International, vol. 36, no. 4, p. 1417-1422. [CrossRef]
11. HOLMES, P.A. (1985). Applications of PHB-a microbially produced biodegradable thermoplastic. Physics in Technology, vol. 16, no. 1, p. 32-36. [CrossRef]
12. Jain, T.K.; Reddy, M.K.; Morales, M.A.; Leslie-Pelecky, D.L. and Labhasetwar, V. (2008). Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Molecular Pharmaceutics, vol. 5, no. 2, p. 316-327. [CrossRef]
13. KIM, D.; LEE, N.; PARK, M.; KIM, B.H.; AN, K. and HYEON, T. (2009). Synthesis of uniform ferrimagnetic magnetite nanocubes. Journal of the American Chemical Society, vol. 131, no. 2, p. 454-455. [CrossRef]
14. LEE, C.M.; JEONG, H.J.; KIM, E.M.; KIM, D.W.; LIM, S.T.; KIM, H.T.; PARK, I.K.; JEONG, Y.Y.; KIM, J.W. and SOHN, M.H. (2009). Superparamagnetic iron oxide nanoparticles as a dual imaging probe for targeting hepatocytes in vivo. Magnetic Resonance Medicine, vol. 62, no. 6, p. 1440-1446. [CrossRef]
15. LIU, X.; KAMINSKI, M.D.; CHEN, H.; TORNO, M.; TAYLOR, L. and ROSENGART, A.J. (2007). Synthesis and characterization of highly-magnetic biodegradable poly (D,L-lactide-co-glycolide) nanospheres. Journal Controlled Release, vol. 119, no. 1, p. 52-58. [CrossRef]
16. MAEDA, H. (2001). The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Advances in Enzyme Regulation, vol. 41, no. 1, p. 189-207. [CrossRef]
17. MIN, Y.; AKBULUT, M.; KRISTIANSEN, K.; GOLAN, Y. and ISRAELACHVILI, J. (2008). The role of interparticle and external forces in nanoparticle assembly. Nature Materials, vol. 7, no. 7, p. 527-538. [CrossRef]
18. NEDKOV, I.; MERODIISKA, T.; SLAVOV, L.; VANDENBERGHE, R.E.; KUSANO, Y. and TAKADA, J. (2006). Surface oxidation, size and shape of nano-sized magnetite obtained by co-precipitation. Journal of Magnetism and Magnetic Materials, vol. 300, no. 2, p. 358-367. [CrossRef]
19. NEL, A.E.; MADLER, L.; VELEGOL, D.; XIA, T.; HOEK, E.M.V.; SOMASUNDARAN, P.; KLAESSIG, F.; CASTRANOVA, V. and THOMPSON, M. (2009). Understanding biophysicochemical interactions at the nano-bio interface. Nature Materials, vol. 8, no. 7, p. 543-557. [CrossRef]
20. Ngaboni Okassa, L.; Marchais, H.; Douziech-Eyrolles, L.; Cohen-Jonathan, S.; Soucé, M.; Dubois, P. and Chourpa, I. (2005). Development and characterization of sub-micron poly (D, L-lactide-co-glycolide) particles loaded with magnetite/maghemite nanoparticles. International Journal of Pharmaceutics, vol. 302, no. 1-2, p. 187-196. [CrossRef]
21. PILLAI, O. and PANCHAGNULA, R. (2001). Polymers in drug delivery. Current Opinion Chemical Biology, vol. 5, no. 4, p. 447-451. [CrossRef]
22. ROY, P.; DAS, S.; BERA, T.; MONDOL, S. and MUKHERJEE, A. (2010). Andrographolide nanoparticles in leishmaniasis: Characterization and in vitro evaluations. International Journal of Nanomedicine, vol. 5, p. 1113-1121. [CrossRef]
23. SANVICENS, N. and MARCO, M.P. (2008). Multifunctional nanoparticles - properties and prospects for their use in human medicine. Trends Biotechnology, vol. 26, no. 8, p. 425-433. [CrossRef]
24. SHI, J.; XIAO, Z.; VOTRUBA, A.R.; VILOS, C. and FAROKHZAD, O.C. (2011). Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery. Angewandte Chemie-International Edition, vol. 50, no. 31, p. 7027-7031. [CrossRef]
25. TEKADE, A.R. and GATTANI, S.G. (2009). Development and evaluation of pulsatile drug delivery system using novel polymer. Pharmaceutical Development and Technology, vol. 14, no. 4, p. 380-387. [CrossRef]
26. UTKAN, G.G.; SAYAR, F.; BATAT, P.; IDE, S.; KRIECHBAUM, M. and PISKIN, E. (2011). Synthesis and characterization of nanomagnetite particles and their polymer coated forms. Journal of Colloid Interface Science, vol. 353, no. 2, p. 372-379. [CrossRef]
27. VILOS, C. and VELÁSQUEZ, L.A. (2012). Therapeutic strategies based on polymeric microparticles. Journal of Biomedicine and Biotechnology, no. 672760, p. 1-9. [CrossRef]
28. Vilos, C.; Constandil, L.; Herrera, N.; Solar, P.; Escobar-Fica, J. and Velásquez, L.A. (2012). Ceftiofur-loaded PHBV microparticles: A potential formulation for a long-acting antibiotic to treat animal infections. Electronic Journal of Biotechnology, vol. 15, no. 4. [CrossRef]
29. Vilos, C.; Morales, F.A.; Solar, P.A.; Herrera, N.S.; Gonzalez-Nilo, F.D.; Aguayo, D.A.; Mendoza, H.L.; Comer, J.; Bravo, M.L.; González, P.A.; Kato, S.; Cuello, M.A.; Alonso, C.; Bravo, E.J.; Bustamante, E.I.; Owen, G.I. and Velásquez, L.A. (2013). Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells. Biomaterials, vol. 34, no. 16, p. 4098-4108. [CrossRef]
30. WANG, Y.; NG, Y.W.; CHEN, Y.; SHUTER, B.; YI, J.; DING, J.; WANG, S.C. and FENG, S.S. (2008). Formulation of superparamagnetic iron oxides by nanoparticles of biodegradable polymers for magnetic resonance Imaging. Advanced Functional Materials, vol. 18, no. 2, p. 308-318. [CrossRef]
31. XU, C. and SUN, S. (2009). Superparamagnetic nanoparticles as targeted probes for diagnostic and therapeutic applications. Dalton Transactions, no. 29, p. 5583-5591. [CrossRef]
32. YANG, J.; PARK, S.B.; YOON, H.G.; HUH, Y.M. and HAAM, S. (2006). Preparation of poly ε-caprolactone nanoparticles containing magnetite for magnetic drug carrier. International Journal of Pharmaceutics, vol. 324, no. 2, p. 185-190. [CrossRef]
33. ZHAO, H.; GAGNON, J. and HAFELI, U.O. (2007). Process and formulation variables in the preparation of injectable and biodegradable magnetic microspheres. Biomagnetic Research and Technology, vol. 5, no. 1, p. 2. [CrossRef]